
Persistent sleep deprivation has the potential to alter the composition of the gut microbiota, which consequently compromises the body’s immune defenses and contributes to the advancement of colon cancer. This finding is particularly relevant given that cancer patients frequently contend with disrupted sleep patterns.
In a recent investigation, scientists affiliated with the University of Florida College of Medicine examined the effects of chronic sleep loss on the gut microbiome and how these changes subsequently impact immune function and the progression of colorectal carcinoma. The findings were formally presented at the American Association for Cancer Research annual meeting in 2026.
It has been widely acknowledged for some time that insufficient sleep weakens our immune system, and numerous prior studies have also explored the correlation between sleep disturbances and the makeup of the gut microbiome.
For instance, a review article published late last year documented a link between sleep aberrations and the intestinal microbiota mediated via the “gut-brain axis,” and a more recently released study further substantiates a clear connection between the gut microbiota and disturbed sleep.
Therefore, the researchers hypothesized that the immune impairment induced by sleep deprivation might be mediated through alterations in the gut microbiota, suggesting this pathway could also influence the course and efficacy of anti-cancer treatments.
Subsequently, the team investigated the impact of sustained sleep deficiency on the gut microbiota and the effectiveness of treating colorectal cancer with 5-fluorouracil (5-FU; a common chemotherapy agent) in a murine model.
The investigators analyzed stool samples from both sleep-deprived and non-deprived tumor-bearing mice to ascertain the microbiota’s influence on tumor growth and the response to 5-FU therapy.
They also examined the presence of immune cells within the tumor microenvironment, crucial genes involved in regulating the circadian rhythm, and various immune system biomarkers across both mouse cohorts.
Furthermore, the researchers implemented fecal microbiota transplants derived from the samples of sleep-deprived mice into mice that were not sleep-deprived but whose native gut flora had been entirely eliminated. This procedure was crucial to isolate the specific effect of the gut flora on cancer progression and treatment response.
The study authors reported that mice subjected to sleep deprivation exhibited not only a shift in their gut flora composition but also accelerated tumor growth (quantified by tumor volume) and diminished responsiveness to chemotherapy.
According to the investigators, modifications were also apparent in genes governing the circadian clock. Following the fecal microbiota transplants, the researchers observed identical outcomes in the previously sleep-deprived mice.
“The lack of sleep altered the composition of the gut flora, and furthermore, we propose it also affected bacterial behavior,” explained study author Maria S. Hernandez. The research indicates that these microbial shifts can have functional consequences for both cancer advancement and the success of anti-cancer interventions.
Sleep difficulties and resultant sleep deficiency are highly prevalent among cancer patients yet are frequently overlooked during treatment protocols, Hernandez continued. This represents a modifiable factor capable of influencing cancer development, disease trajectory, and therapeutic success, with the gut microbiota playing a pivotal role in mediating this impact.
Certainly, achieving optimal sleep is not always feasible, especially when an individual is hospitalized long-term or actively undergoing cancer treatment, but restoring a healthy gut microbiota offers a potential avenue for supporting these patients.
“We possess substantial knowledge regarding the microbiome, and it is time we begin prioritizing its care and treating it with due consideration,” summarized study author Christian Jobin. In addition to obtaining adequate rest, diet stands as a key determinant in cultivating a healthy gut microenvironment.